BR112023000151A2 - Métodos e composições para produzir fusossomas virais - Google Patents
Métodos e composições para produzir fusossomas viraisInfo
- Publication number
- BR112023000151A2 BR112023000151A2 BR112023000151A BR112023000151A BR112023000151A2 BR 112023000151 A2 BR112023000151 A2 BR 112023000151A2 BR 112023000151 A BR112023000151 A BR 112023000151A BR 112023000151 A BR112023000151 A BR 112023000151A BR 112023000151 A2 BR112023000151 A2 BR 112023000151A2
- Authority
- BR
- Brazil
- Prior art keywords
- fusosomes
- compositions
- methods
- producing
- produce viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5184—Virus capsids or envelopes enclosing drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
- C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18211—Henipavirus, e.g. hendra virus
- C12N2760/18222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063048524P | 2020-07-06 | 2020-07-06 | |
| PCT/US2021/040501 WO2022010889A1 (en) | 2020-07-06 | 2021-07-06 | Methods and compositions for producing viral fusosomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023000151A2 true BR112023000151A2 (pt) | 2023-03-14 |
Family
ID=79552689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023000151A BR112023000151A2 (pt) | 2020-07-06 | 2021-07-06 | Métodos e composições para produzir fusossomas virais |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240279685A1 (https=) |
| EP (1) | EP4175622A4 (https=) |
| JP (2) | JP2023534924A (https=) |
| KR (1) | KR20230044420A (https=) |
| CN (1) | CN116157116A (https=) |
| AU (1) | AU2021305060A1 (https=) |
| BR (1) | BR112023000151A2 (https=) |
| CA (1) | CA3188810A1 (https=) |
| IL (1) | IL299658A (https=) |
| MX (1) | MX2023000358A (https=) |
| WO (1) | WO2022010889A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018256925B2 (en) | 2017-04-28 | 2024-11-21 | Agrospheres, Inc. | Compositions and methods for the encapsulation and scalable delivery of agrochemicals |
| US11624061B2 (en) | 2017-04-28 | 2023-04-11 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| BR112020005803A2 (pt) | 2017-09-25 | 2020-12-01 | Agrospheres, Inc. | composições e métodos para produção e administração moduláveis de produtos biológicos |
| US12496274B2 (en) | 2018-11-14 | 2025-12-16 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for compartment-specific cargo delivery |
| JP7657726B2 (ja) | 2019-03-19 | 2025-04-07 | ザ ブロード インスティテュート，インコーポレーテッド | 編集ヌクレオチド配列を編集するための方法および組成物 |
| WO2020252455A1 (en) | 2019-06-13 | 2020-12-17 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| EP4185600A4 (en) | 2020-07-24 | 2024-12-04 | The General Hospital Corporation | Enhanced virus-like particles and methods of use thereof for delivery to cells |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018266111B2 (en) * | 2017-05-08 | 2024-11-07 | Flagship Pioneering Innovations V, Inc. | Compositions for facilitating membrane fusion and uses thereof |
| US12496274B2 (en) * | 2018-11-14 | 2025-12-16 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for compartment-specific cargo delivery |
-
2021
- 2021-07-06 IL IL299658A patent/IL299658A/en unknown
- 2021-07-06 US US18/004,403 patent/US20240279685A1/en active Pending
- 2021-07-06 WO PCT/US2021/040501 patent/WO2022010889A1/en not_active Ceased
- 2021-07-06 KR KR1020237003754A patent/KR20230044420A/ko active Pending
- 2021-07-06 AU AU2021305060A patent/AU2021305060A1/en active Pending
- 2021-07-06 CA CA3188810A patent/CA3188810A1/en active Pending
- 2021-07-06 JP JP2023500330A patent/JP2023534924A/ja active Pending
- 2021-07-06 CN CN202180054642.8A patent/CN116157116A/zh active Pending
- 2021-07-06 BR BR112023000151A patent/BR112023000151A2/pt unknown
- 2021-07-06 MX MX2023000358A patent/MX2023000358A/es unknown
- 2021-07-06 EP EP21838511.0A patent/EP4175622A4/en active Pending
-
2025
- 2025-10-08 JP JP2025170166A patent/JP2025188163A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4175622A4 (en) | 2025-01-29 |
| MX2023000358A (es) | 2023-03-14 |
| CA3188810A1 (en) | 2022-01-13 |
| IL299658A (en) | 2023-03-01 |
| EP4175622A1 (en) | 2023-05-10 |
| JP2025188163A (ja) | 2025-12-25 |
| KR20230044420A (ko) | 2023-04-04 |
| AU2021305060A1 (en) | 2023-02-09 |
| US20240279685A1 (en) | 2024-08-22 |
| CN116157116A (zh) | 2023-05-23 |
| JP2023534924A (ja) | 2023-08-15 |
| WO2022010889A1 (en) | 2022-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023000151A2 (pt) | Métodos e composições para produzir fusossomas virais | |
| BR112021024333A2 (pt) | Composições terapêuticas compreendendo compostos de n,n-dimetiltriptamina deuterado ou parcialmente deuterado | |
| WO2023044006A8 (en) | Compositions and methods for producing circular polyribonucleotides | |
| WO2022040586A3 (en) | Compositions and methods for in vivo generation of car expressing cells | |
| CR20180503A (es) | Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos | |
| BR112022021562A2 (pt) | Partículas interferentes terapêuticas para o coronavírus | |
| BR112023018844A2 (pt) | Composições e métodos para geração de células t gama-delta de células-tronco pluripotentes induzidas | |
| BR112017020525A2 (pt) | processos para a produção de interpolímeros de etileno/alfa-olefina/não conjugados de alto peso molecular com baixos níveis de ramificação de cadeia longa | |
| BR112022016744A2 (pt) | Métodos para reduzir a degradação de polissorbato em formulações de fármaco | |
| WO2022026932A3 (en) | Differentiation of pancreatic endocrine cells | |
| WO2022026933A3 (en) | In vitro differentiation of pancreatic endocrine cells | |
| BR112021024848A2 (pt) | Métodos de purificação de anticorpos e composições dos mesmos | |
| MX2024005818A (es) | Arnip dirigido al angiotensinogeno y uso farmaceutico del mismo. | |
| WO2022016166A3 (en) | Differentiation of trophectoderm lineage cells from pluripotent stem cells | |
| WO2021231263A3 (en) | Nucleic acid amplification methods | |
| MX2024007287A (es) | Composiciones y metodos para producir alulosa. | |
| ECSP21003171A (es) | Dinucleótidos cíclicos como agonistas de sting | |
| UY40418A (es) | Métodos y composiciones para mejorar características de rendimiento en plantas | |
| WO2021016227A8 (en) | Synthetic genetic elements for biomanufacture | |
| MX2021013900A (es) | Expresion de proteinas modificadas en un peroxisoma. | |
| BR112023014906A2 (pt) | Molécula de ácido nucleico funcional e método | |
| MX2023000671A (es) | Edición genética para mejorar la función articular. | |
| BR112022006275A2 (pt) | Célula de levedura, e, método para produzir análogos de poliamina | |
| WO2024137700A3 (en) | Polynucleic acid molecules targeting agt and uses thereof | |
| BR112022015849A2 (pt) | Produção de etanol com um ou mais coprodutos em levedura |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |